Related Experiment Video
Updated: Nov 1, 2025
07:05
Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
6.2K
[Monoaminergic opioids: which one should we choose?]
Lucien Roulet1, Victoria Rollason2, Jules Desmeules2
1Pharmacie des hôpitaux du Nord-Vaudois et de la Broye, 1400 Yverdon.
Revue Medicale Suisse
|June 23, 2021
Summary
Tapentadol offers a mixed-action alternative to tramadol, with fewer drug interactions and genetic variability. While evidence for chronic pain efficacy is limited, it may benefit select patients.
Area of Science:
- Pharmacology and Pain Management
Background:
- Tapentadol and tramadol possess mixed mechanisms of action for pain relief.
- Tramadol's metabolism via CYP450 leads to pharmacokinetic variability and drug-drug interactions.
- Understanding these differences is crucial for optimizing pain management strategies.
Purpose of the Study:
- To compare the pharmacokinetic profiles and potential adverse effect profiles of tapentadol and tramadol.
- To evaluate the implications of differing metabolic pathways on drug interactions and efficacy.
- To assess the current evidence base for the use of these analgesics in chronic pain.
Main Methods:
- Comparative analysis of pharmacological properties.
- Review of existing clinical evidence on efficacy and safety.
- Assessment of metabolic pathways, including CYP450 interactions and genetic polymorphisms.
Main Results:
- Tapentadol lacks analgesically active metabolites and is not significantly metabolized by CYP450, reducing drug interaction risks.
- Tapentadol may present fewer serotoninergic side effects but a higher risk of opioid-related adverse effects compared to tramadol.
- The overall evidence for the efficacy of both agents in chronic pain is currently limited.
Conclusions:
- Tapentadol serves as an additional analgesic option for chronic pain.
- Patient selection requires careful consideration of clinical status, comorbidities, and concurrent medications.
- Further research is needed to establish definitive efficacy and safety profiles for tapentadol in chronic pain management.
More Related Videos
Related Concept Videos
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
599
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
599
01:22Opioid Receptors: Overview
2.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.8K
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
539
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
539
01:25Analgesia and Pain Management
1.0K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.0K
01:17Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
425
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
425
01:23Antidepressant Drugs: MAOIs and Other Agents
521
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
521